Please log in to see the full text of this API!
Telithromycin
-
Synonyms:
HMR-3647, RU-66647
-
ATC:
J01FA15
-
Use:
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:812.02 g/mol
-
CAS-RN:191114-48-4
-
InChI Key:LJVAJPDWBABPEJ-PNUFFHFMSA-N
-
InChI:InChI=1S/C43H65N5O10/c1-12-33-43(8)37(48(41(53)58-43)19-14-13-18-47-23-31(45-24-47)30-16-15-17-44-22-30)27(4)34(49)25(2)21-42(7,54-11)38(28(5)35(50)29(6)39(52)56-33)57-40-36(51)32(46(9)10)20-26(3)55-40/h15-17,22-29,32-33,36-38,40,51H,12-14,18-21H2,1-11H3/t25-,26-,27+,28+,29-,32+,33-,36-,37-,38-,40+,42-,43-/m1/s1
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
108-24-7 |
C4H6O3 |
acetic anhydride |
Acetic acid, anhydride |
530-62-1 |
C7H6N4O |
1,1'-carbonyldiimidazole |
1H-Imidazole, 1,1'-carbonylbis- |
118058-74-5 |
C30H55NO10 |
3-O-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-l-ribo-hexopyranosyl)-6-O-methylerythromycin |
Erythromycin, 3-O-de(2,6-dideoxy-3-C-methyl-3-O-methyl-(-L-ribo-hexopyranosyl)-6-O-methyl- |
244307-89-9 |
C36H54FN3O11 |
(10E)-3-de[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-l-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-2-fluoro-6-O-methyl-3-oxoerythromycin 2'-acetate 12-(1H-imidazole-1-carboxylate) |
Erythromycin, 3-de[(2,6-dideoxy-3-C-methyl-3-O-methyl-(-L-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-2-fluoro-6-O-methyl-3-oxo-, 2'-acetate 12-(1H-imidazole-1-carboxylate), (10E)- |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
|
F |
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
,2002 |
|
J |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
References
-
- US 9 999 999 (Roussel Uclaf; 3.6.1997; F-prior. 3.5.1994).
-
preparation of 6-O-methylerythromycin (clarithromycin):
- EP 999 999 (Taisho Pharm.; appl. 16.12.1987; J-prior. 17.12.1986).
- EP 99 999 (Taisho Pharm.; J-prior. 4.6.1980).
- US 9 999 999 999 (Teva Pharm.; 15.12.2000; USA-prior. 29.2.2000).
- Liao, G.; Zhang, G.; He, T.: Zhongguo Kangshengsu Zazhi (ZKZAEY) 27, 3, 999 (2002).
- KR 9 999 999 999 (Hanmi Pharmac.; ROK-prior. 29.12.1998).
- Allevi, P.; Longo, A.; Anastasia, M.: Bioorg. Med. Chem. (BMECEP) 7, 12, 9999 (1999).
- Watanabe, Y. et al.: Heterocycles (HTCYAM) 31, 12, 9999 (1990).
- EP 999 999 (Taisho Phrm.; 22.3.1985; J-prior. 4.6.1984).
-
process for preparation of erythromycin A oxime:
- US 9 999 999 (Abbott; 15.9.1988; USA-prior. 10.4.1996).
-
preparation of erythromycin derivative IV:
- US 9 999 999 (Roussel Uclaf; 18.6.1996; F-prior. 1.11.1993).
- EP 999 999 (Roussel Uclaf; appl. 11.5.1994; F-prior. 2.7.1993).
-
erythromycin hydrate:
- The Merck Index, 13th Ed., 3626.
-
other erythromycin derivatives:
- EP 999 999 (Roussel Uclaf; appl. 20.11.1991; F-prior. 21.11.1990).
-
preparation of 4-(3-pyridinyl)-1H-imidazole (VIII):
- FR 9 999 999 (Hoechst Marion Roussel; F-prior. 9.7.1998).
- Kirchhoff, E. et al.: Org. Process Res. Dev. (OPRDFK) 5, 1, 99 (2001).
-
alternative preparation of VIII:
- JP 9 999 999 999 (Sumika Fine Chemicals; J-prior. 24.5.2001).
- JP 9 999 999 999 (Sumika Fine Chemicals; J-prior. 24.8.2001).